| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
NET LOSS | |||||||||
-11,945 | 10,288 | 121,132 | 229,929 | -92,646 | - | - | - | - | - |
NET LOSS | |||||||||
- | - | - | - | - | - | - | - | -38,205 | -2,387 |
Adjustments to reconcile net loss to net cash used in operating activities | |||||||||
Interest income earned in cash and investments held in trust account | |||||||||
197,141 | - | - | - | 0 | - | - | - | - | - |
Interest income earned in cash and investments held in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Change in operating assets and liabilities: | |||||||||
Decrease in prepayments | |||||||||
-19,015 | -15,840 | 56,712 | -20,012 | -20,011 | -20,011 | 66,704 | 0 | 0 | 0 |
Increase (decrease) in accrued liabilities | |||||||||
42,446 | 94,006 | 9,249 | -55,955 | -55,175 | 115,000 | -1,818 | -23,632 | 25,683 | 0 |
(Decrease) increase in amount due to related party | |||||||||
-1,234 | - | - | - | 32,564 | - | - | - | 0 | 0 |
Cash used in operating activities | |||||||||
-148,859 | -129,752 | -197,484 | -174,492 | -95,246 | -12,259 | -141,334 | -39,257 | -12,522 | -2,387 |
Cash flows from investing activities | |||||||||
Proceeds deposited in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash used in investing activities | |||||||||
0 | 0 | 0 | 0 | 0 | 0 | -46,000,000 | 0 | 0 | 0 |
Cash flows from financing activities | |||||||||
Proceeds from a related party | |||||||||
48,317 | 110,974 | 109,100 | 62,564 | 0 | 0 | -71,148 | 20,826 | 50,322 | - |
Proceeds from sale of ordinary shares to related party | |||||||||
- | - | - | - | - | 0 | 0 | 0 | 25,000 | 2,387 |
Proceeds from public offering, net of expenses | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Proceeds from private placements to related party | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Payment of offering costs | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | |||||||||
48,317 | 110,974 | 109,100 | 62,564 | 0 | 0 | 46,853,007 | 20,826 | 75,322 | 2,387 |
NET CHANGE IN CASH | |||||||||
-100,542 | -18,778 | -88,384 | -111,928 | -95,246 | -12,259 | 711,673 | -18,431 | 62,800 | 0 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||||||
Unrealized (loss) gain on Trust Account | |||||||||
-22,985 | -48,976 | -17,349 | -58,650 | 277,735 | 0 | 0 | 0 | 0 | - |
Changes in ordinary shares subject to conversion | |||||||||
-34,930 | -38,694 | 103,789 | 171,279 | 185,089 | 0 | 0 | 0 | 0 | - |
Expenses paid by a related party | |||||||||
18,317 | - | - | - | 0 | - | - | - | - | - |
Proceeds of a promissory note deposited in Trust Account by a founder shareholder | |||||||||
460,000 | - | - | - | 0 | - | - | - | - | - |
Deferred offering costs and expenses paid by a related party | |||||||||
- | - | - | - | - | 0 | 113,565 | 62,732 | 13,632 | 95,000 |
Repurchase of ordinary shares from a founder shareholder | |||||||||
- | - | - | - | - | 0 | 0 | 0 | 1 | 0 |
Accrued underwriting compensation | |||||||||
- | - | - | - | - | - | - | - | - | 0 |